ASTRAEA THERAPEUTICS LLC
ASTRAEA THERAPEUTICS LLC is a federal contractor, registered under UEI ZNNQAFC5FXH3 and CAGE code 56HV6. It has been awarded $26,669,472 in federal contracts. Primary work spans Unknown NAICS and Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). Top awarding agencies include Department Of Health And Human Services and Department Of Defense (dod).
Contact Information
Registration and classification details
Registration
UEI Code
ZNNQAFC5FXH3CAGE Code
56HV6Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Astraea Therapeutics LLC specializes in advanced biomedical research and development services, with a focus on therapeutic innovation, preclinical drug discovery, and translational science. The company leverages cutting-edge molecular biology, pharmacokinetic modeling, and targeted delivery systems ...
Astraea Therapeutics LLC specializes in advanced biomedical research and development services, with a focus on therapeutic innovation, preclinical drug discovery, and translational science. The company leverages cutting-edge molecular biology, pharmacokinetic modeling, and targeted delivery systems to advance novel therapeutic candidates from concept to investigational new drug status. Core technical expertise includes oncology and immunotherapy platform development, biomarker identification, and GMP-compatible process scaling. Their differentiation lies in integrating proprietary computational biology tools with wet-lab validation to accelerate candidate selection and reduce development timelines. As a Women-Owned Small Business and Woman-Owned Business certified entity, Astraea Therapeutics brings a mission-driven approach to federally supported life sciences initiatives, emphasizing diversity in R&D leadership and inclusive innovation pipelines. Award history is not available to specify agency engagement patterns, but the company’s NAICS classification under 541715—Scientific Research and Development Services—indicates direct alignment with NIH, DOD’s CDMRP, and BARDA-funded programs focused on therapeutic innovation. Their work likely supports early-phase clinical translation, mechanism-of-action studies, and biologics development under government-sponsored biomedical research initiatives. The company is positioned within the federal biopharmaceutical R&D market, serving as a specialized contractor for complex, high-risk therapeutic projects requiring agile, science-led execution. Their business structure as a small entity enables nimble collaboration with academic partners and federal labs, while their WOSB certifications enhance access to set-aside opportunities in the federal life sciences sector. Headquartered in Mountain View, CA, Astraea Therapeutics operates within a dense innovation ecosystem, leveraging proximity to leading research institutions and biotech infrastructure to support its mission-critical R&D services.
Key Performance Metrics
Awards Count
15
All time
Active
1
Currently performing
Completed
14
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with ASTRAEA THERAPEUTICS LLC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for ASTRAEA THERAPEUTICS LLC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
